Learn more

UNIV NAGOYA NAT UNIV CORP

Overview
  • Total Patents
    1,053
  • GoodIP Patent Rank
    3,097
  • Filing trend
    ⇩ 9.0%
About

UNIV NAGOYA NAT UNIV CORP has a total of 1,053 patent applications. It decreased the IP activity by 9.0%. Its first patent ever was published in 2002. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are OREGON STATE, CENTRE NAT RECH SCIENT and UNIV MICHIGAN STATE.

Patent filings per year

Chart showing UNIV NAGOYA NAT UNIV CORPs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Hori Masaru 55
#2 Ishihara Kazuaki 45
#3 Takada Hiroaki 42
#4 Kurachi Ryo 36
#5 Itami Kenichiro 36
#6 Shamoto Eiji 36
#7 Mizuno Masaaki 32
#8 Ujihara Toru 24
#9 Kamigaito Masami 24
#10 Sato Yoshiaki 23

Latest patents

Publication Filing date Title
US2020295227A1 Semiconductor nanoparticle, method for manufacturing same, and light emitting device
WO2020137804A1 Vapor phase growth apparatus
WO2020090860A1 Mirna extraction method and mirna analysis method
WO2020090859A1 Device to be used for capturing extracellular vesicles, and preservation method and transport method for extracellular vesicles
WO2020071484A1 Method for screening for chemical substance, program, control device, and culture observation device
WO2020054773A1 Device for separation of biomolecules, and operation method therefor
WO2020079993A1 Antipsychotic and use thereof
WO2020095518A1 Method for producing negative thermal expansion material
WO2020045291A1 Laser microdissection device, analysis apparatus including laser microdissection device, and sample collection method
WO2020040243A1 Structure material, structure, method for manufacturing structure, seal composition, and ion supply material
WO2020039984A1 Compound library
TW202021903A Method for separating semiconductor carbon nanotubes, mixed solution, and dispersion
WO2020026987A1 Anti-ror1 monoclonal antibody, functional fragment thereof, gene, drug delivery composition, and pharmaceutical composition
WO2020022503A1 Non-covalent nanocarbon-polymer hybrid composition
WO2020031582A1 Machining device and cutting method
WO2020009231A1 Novel lipase capable of decomposing oil or fat containing trans-fatty acid
WO2020009232A1 Novel microorganisms for decomposing oil and fat containing fatty acid
US2020164375A1 Fluidic device and method for separating biomolcules
WO2020009151A1 Oligonucleotides for controlling tau splicing, and uses thereof
WO2020004337A1 Cd37-specific chimeric antigen receptor